JPRN-UMIN000013932招募中未知
Recurrent Embolism Lessened by Rivaroxaban, an Anti-Xa Agent of Early Dosing for Acute Ischemic Stroke and Transient Ischemic Attack With Atrial Fibrillation Study (RELAXED) - RELAXED: Recurrent Embolism Lessened by Rivaroxaban for Acute Ischemic Stroke
Japan Cardiovascular Research Foundation, and National Cerebral and Cardiovascular Center0 个研究点目标入组 2,000 人开始时间: 2014年5月12日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 2,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable(—)
- 性别
- All
入选标准
- 未提供
排除标准
- •1) hypersensitivity to rivaroxaban 2) Active bleeding (clinically significant hemorrhage) including gastrointestinal hemorrhage 3) liver disease complicated with coagulation disorder 4) liver disorder corresponding to Child-Pugh Class B or C 5) renal failure (creatinine clearance: <15 mL/minute) 6) poorly controlled hypertension (higher than 180/100) 7) Woman who are or are likely to be pregnant 8) Ongoing treatment with HIV protease inhibitors including ritonavir, atazanavir and indinavir 9) Ongoing treatment with itraconazole, voriconazole and ketoconazole 10) Active bacterial endocarditis 11) Patients considered by the investigator to be unsuitable for participating in this study
研究者
相似试验
Unknown
不适用
RELAXED: Recurrent Embolism Lessened by Rivaroxaban for Acute Ischemic StrokeStroke, AcuteAtrial FibrillationNCT02129920Japan Cardiovascular Research Foundation2,000
进行中(未招募)
1 期
The role of Rivaroxaban in the treatment of tumor patients with thrombosisEUCTR2015-001478-16-DEAIO-Studien-gGmbH450
进行中(未招募)
1 期
A comparison between rivaroxaban and placebo for the prevention of deep vein thrombosis or pulmonary embolism afetr laparoscpic surgery for colorectal cancer after initial heparin prophylaxisPrevention of venous thromboembolism after laparoscopic surgery for colorectal cancerMedDRA version: 20.0Level: LLTClassification code 10067650Term: Pulmonary embolism prophylaxisSystem Organ Class: 100000004865MedDRA version: 21.1Level: LLTClassification code 10012108Term: Deep venous thrombosis prophylaxisSystem Organ Class: 100000004865EUCTR2015-005090-20-ITFONDAZIONE FADOI646
已完成
1 期
RIVARAD studyCirculatory SystemPACTR202110633346282hedi chaker hospital512
招募中
不适用
Effect of rivaroxaban for anti-atherosclerotic response in atrial fibrillation patientsatrial fibrillationJPRN-UMIN000011129Yokohama Sakae Kyosai Hospital50
